HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.

Abstract
N-Acylethanolamine acid amidase (NAAA) is a cysteine enzyme that catalyzes the hydrolysis of palmitoylethanolamide (PEA). Pharmacological blockage of NAAA elevates PEA levels and exerts powerful anti-inflammatory activities. We have recently identified a highly potent NAAA inhibitor F215. Here, we demonstrated that F215 was an unusual inflammation-restricted NAAA inhibitor. In lipopolysaccharides (LPS) induced acute lung injury (ALI) model, F215 markedly accelerated inflammation resolution, promoted clearance of neutrophils infiltration and alveolar repair in the lungs. F215 efficiently inhibited NAAA and protected endogenous PEA from degradation in ALI model, but it cannot readily suppress the NAAA activity in naïve mice. The inflammation-restricted effect of F215 was further confirmed in the alveolar macrophage, F215 only increased PEA levels and exerted anti-inflammatory effects in activated macrophages, but not in unstimulated macrophages. Moreover, we also showed that the pharmacological effects of F215 were restricted to the local inflamed skin elicited by 12-o-tetradecanoylphorbol-13-acetate (TPA), but not the normal tissues. We believe that F215 could be a useful probe to investigate the function of NAAA, as well as a potent anti-inflammatory agent, and its inflammation-restricted feature might offer a new approach to prevent potential side effects of systemic enzyme inhibition.
AuthorsYuhang Li, Pan Zhou, Huixia Chen, Qi Chen, Xiaofei Kuang, Canzhong Lu, Jie Ren, Yan Qiu
JournalPharmacological research (Pharmacol Res) Vol. 132 Pg. 7-14 (06 2018) ISSN: 1096-1186 [Electronic] Netherlands
PMID29572189 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • 12-O-tetradecanoylphorbol-1,3-acetate
  • Anti-Inflammatory Agents
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Oxazoles
  • Amidohydrolases
  • NAAA protein, human
  • Tetradecanoylphorbol Acetate
Topics
  • Acute Lung Injury (chemically induced, drug therapy, pathology)
  • Amidohydrolases (antagonists & inhibitors)
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Cells, Cultured
  • Edema (chemically induced, drug therapy)
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Lipopolysaccharides
  • Macrophages, Alveolar (drug effects)
  • Male
  • Mice, Inbred C57BL
  • Mice, Inbred ICR
  • Oxazoles (pharmacology, therapeutic use)
  • Tetradecanoylphorbol Acetate (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: